For people with aspergillosis, asthma, and bronchiectasis, it’s very common to live with long-term Pseudomonas in the lungs.
Hearing that it has become resistant to ciprofloxacin feels frightening, but this does not mean you’ve done anything wrong — or that you’re running out of options.
Here’s why resistance happens:
1. Bronchiectasis airways allow bacteria to settle long-term
The widened, inflamed airways seen in ABPA and bronchiectasis create places where mucus pools and bacteria survive for months or years.
2. Pseudomonas forms “biofilms”
These are sticky layers that protect the bacteria from antibiotics.
Inside them, Pseudomonas can:
-
swap resistance genes
-
slowly mutate
-
become harder to kill
This can happen even without taking antibiotics recently.
3. Your sputum contains a mixture of different strains
Some strains may have been slightly resistant for years.
One strain can suddenly become dominant — and that’s what shows up on the lab test.
So developing resistance is normal in chronic lung disease and not a sign your lungs have suddenly worsened.
Does ciprofloxacin resistance mean IV antibiotics are the only option now?
No — not automatically.
Your team will look at the full sensitivity report to see what is still effective.
Possible options include:
1. Nebulised antibiotics
These are widely used in people with ABPA + bronchiectasis because they act directly in the lungs with fewer body-wide effects.
Common inhaled antibiotics:
-
Colistin
-
Tobramycin
-
Aztreonam
These often have very little impact on the gut microbiome.
2. Other oral antibiotics (if sensitive)
Sometimes alternatives still work, depending on the report.
3. A “suppression” plan
Some patients use inhaled antibiotics on a regular cycle to keep symptoms down and reduce flare-ups.
IV antibiotics are only needed if:
-
symptoms become severe
-
there are no suitable oral or inhaled options
-
your team wants a stronger “clean-out” of the lungs
Even then, it does not mean hospital admission — many patients receive IVs at home.
If IV treatment is recommended
It’s completely normal to feel nervous — especially if you’ve never had IV therapy before.
But here is the part most people find reassuring:
1. The treatment is closely monitored
Blood tests, kidney checks, and hearing tests are routine.
Your team will adjust the dose if needed.
2. Many people feel significantly better afterwards
Patients often say their lungs feel “lighter,” with:
-
less sputum
-
easier breathing
-
fewer flare-ups
-
more energy
3. Home IV therapy is common
Specialist nurses can support you, and it’s usually temporary.
What about the microbiome?
This is a valid concern, especially for people with long-term lung conditions.
Good news:
-
Nebulised antibiotics hardly affect the gut microbiome at all.
-
IV antibiotics mainly affect it short-term, and most people return to baseline once treatment stops.
-
Your team can help you protect your gut during treatment.
What should you do next?
Here’s a simple plan:
-
Ask for the full sensitivity report.
There may be several antibiotics still effective. -
Discuss inhaled options.
Many ABPA/bronchiectasis patients manage very well with nebulised therapy. -
Ask whether this resistance result needs repeating.
Sometimes it reflects one resistant pocket within the biofilm rather than the whole population. -
Talk through what an IV plan would look like
— including home options and support.
Final reassurance
Ciprofloxacin resistance is extremely common in people with aspergillosis, ABPA, and bronchiectasis.
It does not mean:
-
your disease is progressing
-
you caused the resistance
-
you are running out of treatment
-
IV is your only option
It simply reflects how clever Pseudomonas is — and how complex airways behave in chronic aspergillosis.
Your team will still have a range of effective treatments.
Share this post
Latest News posts
Recent Aspergillosis Research – January 2026 (week 2)
January 16, 2026
Sinusitis in Patients with ABPA
January 16, 2026
Hydrocortisone dosing in adrenal insufficiency
January 5, 2026
Season’s Greeting
December 24, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
